Klein Lawrence Otto sold ORKA
October 1, 2026 · Form 4 insider transaction
Klein Lawrence Otto sold 200 shares of Oruka Therapeutics, Inc. at $84.78 per share, a transaction worth $17.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
200
Price
$84.78
Total value
$17.0K
InsiderKlein Lawrence Otto
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateOctober 1, 2026
Filing dateOctober 2, 2026
Shares owned after923,128
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These sales were effected pursuant to a Rule 10b5-1 trading plan entered into on May 14, 2026.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.75 to $84.81, inclusive.